cp wire

CP Wire Articles

Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
  • Switching to Tremfya at week 28 after inadequate response to Humira, led to a sustained improvement
  • Tremfya is a human monoclonal antibody


The Janssen Pharmaceutical... read more

Wed, 09/12/18 - 09:14 am
OncoResponse Books $40 Million in Series B Financing
  • New investors include Qatar Investment Authority and Redmile Group
  • Funds will be used to advance 5 drug candidates

OncoResponse announced on 9/11/18 the completion of a... read more

Tue, 09/11/18 - 09:08 am
OPKO Responds to Nasdaq Halt of Trading of Common Shares

OPKO Health, Inc. (NASDAQ:OPK) has had trading in its common stock halted by The Nasdaq Stock Market, and the exchange has advised OPKO that the halt will continue until the company responds (to... read more

Tue, 09/11/18 - 08:55 am
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced on 9/10/18 publication of additional data from a Phase 2 single center, double-blind, placebo-controlled study to examine the safety and... read more

Mon, 09/10/18 - 09:53 am
Scilex Raises $140 Million to Support Commercialization of Non-Opioid Topical Pain Medication System
  • One analyst predicts peak revenue of 1.1billion in 2025
  • Over 1.1 million lidocaine patches sold in the US in 2017


Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (“... read more

Mon, 09/10/18 - 09:13 am

Pages